| OXAGEN LIMITED Patent applications |
| Patent application number | Title | Published |
|---|
| 20110268693 | Compounds Having CRTH2 Antagonist Activity - Compounds of general formula (I) wherein R is phenyl optionally substituted with one or more halo substituents; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis. | 11-03-2011 |
| 20110142855 | Compounds Having CRTH2 Antagonist Activity - Compounds of general formula (I) | 06-16-2011 |
| 20110124683 | Use of CRTH2 Antagonist Compounds - The invention relates to compounds of general formula (I): | 05-26-2011 |
| 20110123547 | Compounds Having CRTH2 Antagonist Activity - Compounds of general formula (II) | 05-26-2011 |
| 20100330077 | 1-ACETIC ACID-INDOLE DERIVATIVES WITH PGD2 ANTAGONIST ACTIVITY - Compounds of general formula (I) | 12-30-2010 |
| 20100266535 | Compounds Having CRTH2 Antagonist Activity - Compounds of general formula (II) | 10-21-2010 |
| 20100063103 | Compounds Having CRTH2 Antagonist Activity - Compounds of general formula (I) | 03-11-2010 |
| 20100056544 | Salts with CRTH2 Antagonist Activity - The potassium, sodium, ammonium, lysine, diethylamine, tromethamine (TRIS), piperazine, ethylenediamine and ethanolamine salt of a compound of general formula (I): wherein R | 03-04-2010 |
| 20100041699 | MICROCRYSTALLINE (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL) ACETIC ACID - The invention relates to a microcrystalline form of a compound which is an inhibitor of PGD | 02-18-2010 |
| 20100035956 | Compounds Having CRTH2 Antagonist Activity - Compounds of general formula (I) wherein R is phenyl optionally substituted with one or more halo substituents; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis. | 02-11-2010 |
| 20100022613 | Compounds Having CRTH2 Antagonist Activity - Compounds of general formula (I) | 01-28-2010 |
| 20090192195 | Compounds Having CRTH2 Antagonist Activity - Compounds of general formula (I) | 07-30-2009 |
| 20090023788 | Treatment of CRTH2-mediated diseases and conditions - The present invention provides indole derivatives that antagonize prostaglandin D | 01-22-2009 |
| 20090018338 | Treatment of CRTH2-Mediated diseases and conditions - The present invention provides indole derivatives that antagonize prostaglandin D | 01-15-2009 |
| 20090018139 | Treatment of CRTH2-mediated diseases and conditions - The present invention provides indole derivatives that antagonize prostaglandin D | 01-15-2009 |
| 20090018138 | Treatment of CRTH2-mediated diseases and conditions - The present invention provides indole derivatives that antagonize prostaglandin D | 01-15-2009 |
